# ADVANCE AI — Requirements Package
**Date:** 2026-06-04  
**Feature Opportunity:** Medical Intelligence Integration Hub for MSL Teams  
**Linked Analysis:** [market-analysis-2026-06-04.md](market-analysis-2026-06-04.md)

---

## Feature Opportunity: Unified Third-Party Data Integration for MSL Workflows

**Problem (from market analysis):** MSLs today context-switch across 4–6 disconnected tools (CRM, payer data, clinical trial databases, content libraries, patient insight platforms) to prepare for a single HCP engagement. No platform provides a unified, compliance-embedded intelligence layer. This is the #1 driver of CRM abandonment and low field data quality across the industry.

**Opportunity:** ADVANCE AI can differentiate as the integration hub for MSL teams by providing pre-built, compliant connectors to the most-used medical affairs data sources (EHR feeds, payer/formulary data, clinical literature, conference abstracts, patient insights), surfaced contextually within the MSL's native workflow.

---

## User Stories

### Story 1: Pre-Call Intelligence Briefing
**As an** MSL preparing for an HCP meeting,  
**I want** a single consolidated pre-call brief that automatically surfaces relevant literature, the HCP's recent publications, payer coverage status for my therapy area, and any outstanding safety follow-ups,  
**so that** I can arrive scientifically prepared and compliant without spending 45+ minutes manually assembling information across multiple tools.

**Acceptance Criteria:**

*Given* an MSL opens a scheduled HCP meeting record in ADVANCE AI,  
*When* the meeting is within 72 hours,  
*Then* the system auto-generates a pre-call brief containing: (a) top 5 relevant publications from the last 90 days, (b) HCP's recent presentations/publications, (c) current formulary/payer coverage summary from integrated market access data, (d) any open safety follow-up items flagged for this HCP.

*Given* an MSL's territory includes integrated data from a third-party payer database (e.g., MMIT),  
*When* formulary status for a covered therapy changes,  
*Then* the brief automatically reflects the updated status and highlights the change.

*Given* a pre-call brief is generated,  
*When* the MSL reviews it,  
*Then* all scientific content is marked with source attribution and date, and any content pending MLR review is clearly flagged and non-shareable.

---

### Story 2: Automated Adverse Event Detection in Field Notes
**As a** medical compliance officer overseeing an MSL field team,  
**I want** the platform to automatically detect and flag potential adverse event (AE) or product quality complaint (PQC) signals in MSL field notes as they are submitted,  
**so that** my team meets pharmacovigilance reporting obligations without relying on MSLs to manually self-identify and escalate every potential signal.

**Acceptance Criteria:**

*Given* an MSL submits a field interaction note containing text,  
*When* the AI analysis identifies language patterns associated with adverse events (symptoms, outcomes, patient-reported harm),  
*Then* the note is automatically flagged with an AE alert, routed to the safety team queue, and the MSL receives an in-app notification within 60 seconds of submission.

*Given* an AE flag is generated,  
*When* it is reviewed by the safety team,  
*Then* the system captures the reviewer, timestamp, resolution status, and any follow-up actions in an immutable audit log.

*Given* the AE detection model is active,  
*When* it is evaluated on a quarterly basis,  
*Then* precision ≥ 85% and recall ≥ 90% against a labeled validation set of known AE reports must be maintained; model drift below threshold triggers an alert to the PM.

---

### Story 3: Third-Party Data Connector Configuration
**As a** ADVANCE AI platform admin at a mid-market biotech,  
**I want** to configure and enable pre-built integrations with our existing data vendors (e.g., MMIT for payer data, a clinical trial registry, our content management system) through a self-service UI,  
**so that** my MSL team can access enriched data within 2 weeks of go-live without requiring a custom engineering engagement.

**Acceptance Criteria:**

*Given* an admin navigates to the Integrations configuration panel,  
*When* they select a supported connector (e.g., MMIT, Medidata, Veeva Vault, PubMed, internal SharePoint),  
*Then* the system presents a guided 5-step setup wizard requiring only API credentials and field-mapping configuration — no code required.

*Given* a connector is configured,  
*When* a scheduled sync runs,  
*Then* the sync completes within 30 minutes for initial load of up to 500K records, with subsequent delta syncs completing within 5 minutes; failures surface actionable error messages to the admin.

*Given* a data connector is live,  
*When* an MSL accesses enriched data in their workflow,  
*Then* the source system, last-sync timestamp, and data freshness indicator are visible inline so MSLs can assess data currency before using it in HCP conversations.

---

### Story 4: Conference & Congress Intelligence
**As an** MSL team lead preparing for a major therapeutic-area congress,  
**I want** the platform to automatically analyze submitted abstracts and flag the most relevant presentations for my therapy area and target KOL list,  
**so that** my team spends preparation time on strategic prioritization rather than manual abstract triage.

**Acceptance Criteria:**

*Given* a congress is added to the ADVANCE AI congress calendar (via name or conference ID),  
*When* abstracts are published (detected via integrated data feed or manual upload),  
*Then* the system scores and ranks abstracts by relevance to the team's configured therapy areas and KOL watchlists, delivering a prioritized reading list to each MSL within 4 hours of publication.

*Given* the prioritized abstract list is delivered,  
*When* an MSL selects an abstract,  
*Then* the system surfaces an AI-generated 3-sentence summary, identifies presenting authors who match KOLs in the CRM, and pre-populates a meeting request template for post-congress follow-up.

*Given* the congress is ongoing,  
*When* late-breaking results are posted,  
*Then* the system detects and delivers an alert to relevant MSLs within 2 hours, distinguishing late-breaking content from previously analyzed abstracts.

---

### Story 5: Cross-Functional Insight Sharing Dashboard
**As a** medical affairs director,  
**I want** to view aggregated MSL field insights — emerging HCP questions, sentiment trends, competitive intelligence signals — in a dashboard shared with commercial and regulatory stakeholders,  
**so that** strategic decisions are informed by real-time field intelligence rather than lagging quarterly reports.

**Acceptance Criteria:**

*Given* MSLs have submitted field interaction notes over a rolling 30-day period,  
*When* a medical affairs director opens the Insights Dashboard,  
*Then* the system displays: (a) top 10 emerging questions by theme and frequency, (b) sentiment trend by therapy area (positive/neutral/negative), (c) competitive product mentions flagged with source count, (d) geographic heat map of HCP engagement intensity — all updated within 24 hours of new notes.

*Given* a director wants to share insight data with a commercial colleague,  
*When* they export or share the dashboard,  
*Then* the system applies role-based data filters automatically — commercial users see aggregated trends without access to individual HCP-identifiable interaction records, preserving firewall compliance.

*Given* a significant trend spike is detected (e.g., >200% week-over-week increase in a query theme),  
*When* the spike persists for 48 hours,  
*Then* the system sends an automated alert to the medical affairs director and the linked product PM with the trend summary and drill-down link.

---

## Product Spec: Medical Intelligence Integration Hub

### Problem Statement
MSL teams at mid-market biotech and specialty pharma operate across 4–6 disconnected data tools per engagement cycle. This fragmentation drives 45+ minutes of manual pre-call assembly, poor field data quality (contributing to the industry's 50–63% CRM abandonment rate), pharmacovigilance exposure from missed AE detection, and slow insight-to-strategy cycles. The Veeva–Salesforce decoupling has created an active switching window that ADVANCE AI can capitalize on.

### Proposed Solution
Build a **Medical Intelligence Integration Hub** as a core product module within the ADVANCE AI MSL platform, delivering:

1. **Pre-built third-party connectors** (MMIT, PubMed, Veeva Vault, Medidata, SharePoint, Salesforce) configurable via a self-service admin UI — no custom engineering required
2. **Automated pre-call briefing** surfacing contextual intelligence from connected data sources within the MSL workflow
3. **AI-powered AE/PQC detection** embedded in note-submission with automated pharmacovigilance routing
4. **Congress Intelligence** — abstract triage, KOL matching, and late-breaking alert delivery
5. **Cross-functional insights dashboard** with role-based data access controls

### Success Metrics
| Metric | Baseline (industry) | Target (12 months post-launch) |
|---|---|---|
| Pre-call prep time per MSL | 45–60 min | ≤ 20 min |
| CRM adoption rate (notes submitted / meetings logged) | ~40–50% | ≥ 75% |
| AE detection recall rate | Manual / ad hoc | ≥ 90% automated detection |
| Time from field note to insight dashboard | 1–4 weeks (manual QBR) | ≤ 24 hours |
| Integration setup time (admin to live) | 4–12 weeks (custom eng) | ≤ 2 weeks (self-serve) |
| Net Promoter Score (MSL users) | — | ≥ 50 |

### Out of Scope (v1)
- Building proprietary payer data or clinical databases (integration-first approach; data ownership remains with vendors)
- AI-generated promotional or marketing content (MLR-approved content only; outside medical affairs mandate)
- Patient-facing tools or direct HCP engagement automation (human MSL remains the engagement principal)
- Real-time EHR write-back or clinical decision support (regulatory pathway complexity deferred to v2)
- Full clinical trial management or IND/NDA regulatory submission workflows

---

*Linked market analysis: [market-analysis-2026-06-04.md](market-analysis-2026-06-04.md)*
